Personas / Equipo Humano

Judith Usall I Rodié

Buscador de publicaciones

Publicaciones

  • Dolz M, Tor J, De la Serna E, Pardo M, Muñoz D, Rodríguez-Pascual M, Puig O, Sugranyes G, Usall J, Sánchez-Gistau V and Baeza I.

    Characterization of children and adolescents with psychosis risk syndrome: The Children and Adolescents Psychosis Risk Syndrome (CAPRIS) study.

    EARLY INTERVENTION IN PSYCHIATRY . 13(5): 1062-1072. Nº de citas: 13

    [doi:10.1111/eip.12728]

  • Marco-Garcia S, Ferrer-Quintero M, Usall J, Ochoa S, del Cacho N and Huerta-Ramos ME.

    Reconocimiento facial de emociones en trastornos neurologicos: una revision narrativa.

    REVISTA DE NEUROLOGIA . 69(5): 207-219. Nº de citas: 12

    [doi:10.33588/rn.6905.2019047]

  • Nuñez C, Stephan-Otto C, Usall J, Bioque M, Lobo A, González-Pinto A, Pina-Camacho L, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Butjosa A, Janssen J, Bibiana Cabrera Llorca, Parellada M, Bernardo M and PEPs group.

    Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis

    SCHIZOPHRENIA BULLETIN . 45(4): 846-858. Nº de citas: 29

    [doi:10.1093/schbul/sby113]

  • del Cacho N, Butjosa A, Vila R, Cuadras-Palleja D, Kaplan M, Rubio E, Pardo M, Muñoz D, Cuevas-Esteban J, GERARDO SAENZ DE NAVARRETE RIBERA, PROFEP group and Usall J.

    Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences

    PSYCHIATRY RESEARCH . 276: 218-222. Nº de citas: 10

    [doi:10.1016/j.psychres.2019.03.027]

  • Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.

    Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.

    EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Nº de citas: 7

    [doi:10.1111/eip.12498]

  • Ballesteros A, Sánchez-Torres AM, López-Ilundain JM, Cabrera B, Lobo A, González-Pinto AM, Díaz-Caneja C, Corripio I, Vieta E, de la Serna E, Bobes J, Usall J, Contreras F, Lorente-Omeñaca R, Mezquida G, Bernardo M, Cuesta MJ and PEPs Group.

    Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    PSYCHOLOGICAL MEDICINE . 48(13): 2247-2256. Nº de citas: 35

    [doi:10.1017/S0033291717003774]

  • Paipa N, Stephan-Otto C, Cuevas-Esteban J, Araceli Núñez Navarro, Usall J and Brebion G.

    Second-to-fourth digit length ratio is associated with negative and affective symptoms in schizophrenia patients.

    SCHIZOPHRENIA RESEARCH . 199: 297-303. Nº de citas: 10

    [doi:10.1016/j.schres.2018.02.037]

  • Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.

    Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.

    BMJ Open . 8(7): . Nº de citas: 6

    [doi:10.1136/bmjopen-2017-021346]

  • Soria V, González-Rodríguez A, Huerta-Ramos ME, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group and Labad J.

    Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.

    PSYCHONEUROENDOCRINOLOGY . 93: 8-19. Nº de citas: 50

    [doi:10.1016/j.psyneuen.2018.04.012]

  • Sánchez Autet M, Garriga M, Zamora FJ, González I, Usall J, Tolosa L, Benítez C, Puertas R and Arranz B.

    Screening of alcohol use disorders in psychiatric outpatients: influence of gender, age, and psychiatric diagnosis.

    Adicciones . 30(4): 251-263. Nº de citas: 4

    [doi:10.20882/adicciones.885]